全球內分泌檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計內分泌檢測市場將從 2025 年的 38.9 億美元成長到 2034 年的 80.1 億美元，2026 年至 2034 年的複合年成長率為 8.36%。

由於糖尿病、甲狀腺功能障礙和腎上腺功能不全等荷爾蒙相關疾病的盛行率不斷上升，全球內分泌檢測市場正穩定成長。人們對疾病早期檢測和預防醫學的日益重視，推動了定期內分泌檢測的普及。人口老化和文明病相關的健康問題也促使全球對診斷檢測服務的需求不斷成長。

關鍵成長要素包括免疫檢測和自動化診斷分析儀技術的進步，這些技術能夠提供準確快速的檢測結果。新興市場對就地檢驗解決方案的日益普及以及檢查室基礎設施的改善，進一步推動了市場成長。此外，醫療保健支出的成長以及政府針對慢性病管理的政策也為市場發展提供了支持。

未來前景一片光明，主要得益於個人化醫療的日益普及和荷爾蒙療法的拓展。數位健康平台與人工智慧診斷技術的融合有望提升檢測的準確性和效率。加大對研發和診斷技術創新的投入預計將推動該領域取得進一步進展。隨著人們對內分泌健康意識的不斷提高，全球市場預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球內分泌檢測市場：依檢測類型分類

• 市場分析、洞察與預測
• 人類絨毛膜促性腺激素分泌(HCG) 荷爾蒙檢測
• 甲狀腺刺激素（TSH）檢測
• 胰島素測試
• 孕酮測試
• 黃體激素(LH) 檢測
• 催乳素試驗
• 其他測試類型

第5章 全球內分泌檢測市場：依技術分類

• 市場分析、洞察與預測
• 免疫檢測
• 質譜分析
• 層析法
• 基於核酸的
• 其他技術

第6章：全球內分泌檢測市場：依最終用途分類

• 市場分析、洞察與預測
• 臨床檢查室
• 醫院
• 診斷中心
• 其他最終用戶

第7章 全球內分泌檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Agilent
  • Beckman Coulter
  • Bio RAD
  • Biomedical Technologies
  • Biomerieux
  • DH Tech
  • Diasorin
  • Labcorp
  • Quidelortho
  • Qiagen
  • Quest Diagnostics
  • Roche

The Endocrine Testing Market size is expected to reach USD 8.01 Billion in 2034 from USD 3.89 Billion (2025) growing at a CAGR of 8.36% during 2026-2034.

The Global Endocrine Testing Market is growing steadily due to the rising prevalence of hormonal disorders such as diabetes, thyroid dysfunction, and adrenal imbalances. Increasing awareness about early disease detection and preventive healthcare is encouraging routine endocrine assessments. Expanding geriatric populations and lifestyle-related health conditions are also contributing to greater demand for diagnostic testing services worldwide.

Major growth drivers include technological advancements in immunoassays and automated diagnostic analyzers that provide accurate and rapid results. Growing adoption of point-of-care testing solutions and improved laboratory infrastructure in emerging markets are further fueling expansion. Additionally, rising healthcare expenditure and government initiatives focused on chronic disease management are supporting market development.

Future prospects appear promising as personalized medicine gains traction and hormone-based therapies expand. Integration of digital health platforms and AI-powered diagnostics may enhance test accuracy and efficiency. Increasing investments in research and diagnostic innovation are expected to drive further advancements. As awareness about endocrine health continues to rise, sustained market growth is anticipated globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Human Chorionic Gonadotropin (HCG) Hormone Test
• Thyroid Stimulating Hormone (TSH) Test
• Insulin Test
• Progesterone Test
• Luteinizing Hormone (LH) Test
• Prolactin Test
• Other Test Types

By Technology

• Immunoassay
• Mass Spectroscopy
• Chromatography
• Nucleic Acid Based
• Other Technologies

By End Use

• Clinical Laboratories
• Hospitals
• Diagnostic Centers
• Other End Users

COMPANIES PROFILED

• Abbott, Agilent, Beckman Coulter, Bio RAD, Biomedical Technologies, Biomerieux, DH Tech, Diasorin, Labcorp, Quidelortho, Qiagen, Quest Diagnostics, Roche
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENDOCRINE TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Human Chorionic Gonadotropin (HCG) Hormone Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Thyroid Stimulating Hormone (TSH) Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Insulin Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Progesterone Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Luteinizing Hormone (LH) Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Prolactin Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENDOCRINE TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Mass Spectroscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nucleic Acid Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENDOCRINE TESTING MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENDOCRINE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Test Type
  • 7.2.2 By Technology
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Test Type
  • 7.3.2 By Technology
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Test Type
  • 7.4.2 By Technology
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Test Type
  • 7.5.2 By Technology
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Test Type
  • 7.6.2 By Technology
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ENDOCRINE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Agilent
  • 9.2.3 Beckman Coulter
  • 9.2.4 Bio RAD
  • 9.2.5 Biomedical Technologies
  • 9.2.6 Biomerieux
  • 9.2.7 DH Tech
  • 9.2.8 Diasorin
  • 9.2.9 Labcorp
  • 9.2.10 Quidelortho
  • 9.2.11 Qiagen
  • 9.2.12 Quest Diagnostics
  • 9.2.13 Roche